|
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
|
Item 5.03 |
- Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
|
Item 9.01 |
Financial Statements and Exhibits
|
3.2 |
Amended and Restated Bylaws – Effective February 11, 2020.
|
BALCHEM CORPORATION
|
||
By:
|
/s/ Mark Stach | |
Mark Stach, General Counsel and Secretary
|
||
Dated: February 12, 2021
|